Articles published in Journal of Clinical Research & Bioethics have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Research & Bioethics has got h-index 19, which means every article in Journal of Clinical Research & Bioethics has got 19 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical Research & Bioethics.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
60 | 61 | 52 | 9 | 16 |
Year wise citations received |
155 | 184 | 182 | 171 | 162 |
Journal total citations count | 1808 |
Journal Impact Factor | 1.91 |
Journal 5 years Impact Factor | 2.41 |
Journal CiteScore | 5.23 |
Journal h-index | 19 |
Mallath MK, Chawla T (2017) Investigators' viewpoint of clinical trials in India: Past, present and future. Perspectives in Clinical Research 8: 31.
Tarling TE, Lasser F, Carter C, Matzke LA, Dhugga G et al (2017) Business Planning for a Campus-Wide Biobank. Biopreservation and Biobanking 15: 37-45.
Kong CC, Tarling TE, Strahlendorf C, Dittrick M, Vercauteren SM (2016) Opinions of Adolescents and Parents About Pediatric Biobanking. Journal of Adolescent Health 58: 474-480.
Kheir AE, Dafaalla M, Bashir A, Abuelgasim N, Abdalrahman I (2016) Medicolegal awareness amongst health professionals in Sudan-where are we now?. Online J Clin Audits 8:4.
Musazzi UM, Marini V, Casiraghi A, Minghetti P (2017) Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials?. Drug Discovery Today 9: 11.
Brand R, Wolff W, Ziegler M (2016) Drugs as instruments: describing and testing a behavioral approach to the study of neuroenhancement. Frontiers in psychology 1;7.
Dubljević V, Ryan CJ (2015) Cognitive enhancement with methylphenidate and modafinil: conceptual advances and societal implications. Neurol Neurosci 4: 25-33.
Garasic MD, Lavazza A (2016) Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts. BMC medical ethics 17: 18.
Kusaczuk M, Krętowski R, Stypułkowska A, Cechowska-Pasko M (2016) Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor–belinostat–in glioblastoma cell lines: a preliminary report. Investigational New Drugs 34: 552-564.
KALKAN R (2009) Educaation and Academic Degrees. Cancer.
Steponaitis G, Kazlauskas A, Skiriute D, Valiulyte I, Skauminas K (2016) Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma. Oncology Letters 12: 3305-3311.
Munung NS (2015) African researchers' perceptions and expectations of the benefits of genomics research in Africa: a qualitative study, Doctoral dissertation, University of Cape Town.
Okoro EO (2017) Effective Treatment Matters: Revitalizing Pharmacovigilance. InPharmacovigilance. Springer International Publishing pp. 121-130.
Groisman IJ, Godard B (2016) Impact of Next Generation Sequencing on the Organization and Funding of Returning Research Results: Survey of Canadian Research Ethics Boards Members. PloS one 11: e0154965.
Haqiqi MA, Pourmoshir N, Bereshneh AH (2016) Clinical and Genetic Aspects of Oral Lichen Planus. International J Biomedical Adv Res 7: 251-256.
Dhama N (2015) Stem Cell Research Therapy for Neurodegenerative Disorders - In What Way to Make it Work 4: 2.
Meller R (2015) Addressing Benefits, Risks and Consent in Next Generation Sequencing Studies. J clin Res bioethics 6: 6.
Dhama N (2015) Stem Cell Research Therapy for Neurodegenerative Disorders - In What Way to Make it Work 4: 5
Behnia F, Elojeimy S, Matesan M, Fajgenbaum DC (2016) Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome. Annals of Hematology 16: 1-4.
Gamboa-Bernal GA (2016) LA EDICIÓN DE GENES A ESTUDIO: LOS PROBLEMAS BIOÉTICOS QUE PUEDE TENER ESTA NUEVA TECNOLOGÍA. Persona y Bioética 9; 20.